Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
05/1999
05/06/1999DE19749717A1 New epothilone derivatives
05/06/1999CA2308327A1 Sarcodictyin and eleutherobin useful for stabilising microtubules
04/1999
04/29/1999WO1999020629A1 7-methylidene-5-oxo-furo fused naphthopyrans
04/29/1999WO1999020274A1 Tetracyclic triterpene derivatives with immunosuppressant activity
04/29/1999DE19748928A1 New epothilone derivatives
04/28/1999EP0910428A1 Photopheresis treatment of chronic hcv infections
04/28/1999EP0559738B1 Methods for detection and quantitation of cell subsets within subpopulations of a mixed cell population
04/28/1999CN1215390A Substituted phenyl keto enols as pesticides and herbicides
04/28/1999CN1215055A Sesquilterpenic internal ester compound for anti-ulcer of alimentary tract
04/22/1999WO1999019317A1 Halogen substituted tetracyclic tetrahydrofuran derivatives
04/21/1999CN1214717A Coating composition comprising bicyclo- or spiro-orthoester-functional compound
04/21/1999CN1214636A Photpheresis treatment of chronic HCV infections
04/20/1999CA2165806C Antiparasitic agents
04/15/1999WO1999018109A1 Ring e-modified analogues of (-)-podophyllotoxin and etoposide and a method for their synthesis
04/15/1999WO1999018108A1 Diacetal composition, process for the preparation of the same, nucleating agent for polyolefins containing the same, polyolefin resin compositions, and moldings
04/15/1999DE19843724A1 Chiral compound used as polymerizable, high-twisting-power dopant for the production of cholesteric networks
04/14/1999EP0908460A1 A process for the simultaneous production of artemisinin and essential oil from the plant artemisia annua
04/14/1999EP0907652A1 Immunosuppressive compounds and methods
04/14/1999EP0907647A1 Crown calix 4]arenes, method of preparation and use for selective extraction of caesium
04/13/1999CA2155236C Gas phase polymerization process
04/13/1999CA2045553C Process for the preparation of vinyl ethers
04/08/1999WO1999016832A1 Aromatic-substituted xanthene dyes
04/08/1999WO1999016453A1 Method for the treatment of cystic fibrosis
04/08/1999CA2304482A1 Method for the treatment of cystic fibrosis
04/07/1999EP0906287A1 Substituted pyrazolyl-pyrazole derivatives and their use as herbicides
04/07/1999EP0632033B1 Novel benzopyran derivative
04/06/1999US5892060 Method for the preparation of (+)-calanolide a and analogues thereof
04/06/1999US5891626 Enzyme-linked analysis; using surfactant
04/06/1999CA1340479C Indane derivatives, process for preparing the same, new intermediates produced, use thereof as therapeutic agents and pharmaceutical compositions containing them
03/1999
03/31/1999EP0737185B1 7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl] 3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereof
03/31/1999EP0659752B1 Antibacterial and anti-tumor epoxide derivate dc 114-a1
03/30/1999US5888829 Photolabile caged ionophores and method of using in a membrane separation process
03/30/1999CA2168731C Antiparasitic agents
03/25/1999WO1999014226A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
03/25/1999CA2303299A1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
03/24/1999EP0903348A1 Epothilone derivatives, preparation and utilization
03/23/1999US5886242 Dopes for nematic or cholesteric liquid crystals in order to produce layers which reflect in colors; comprising a polyvalent chiral group, at least one unsaturated group, at least one spacer and at least one mesogenic polyvalent chiral
03/23/1999US5886185 Polyamine-linked acridine dimers
03/18/1999WO1999012921A1 Thromboxane ligands
03/18/1999WO1999012541A1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces
03/18/1999CA2302555A1 Thromboxane ligands
03/17/1999EP0901493A1 Process for the preparation of an indacene compound
03/17/1999EP0626954B1 Benzocycloheptenes, benzoxepines and benzothiepines
03/17/1999CN1211254A Fused pyrrolo (2,3-C) carbazole-6-ones which potentiate activity of gamma interferon
03/17/1999CN1211244A Radicicol derivatives
03/16/1999US5883119 Triterpene derivatives with immunosuppressant activity
03/16/1999US5883080 Antiparastic auermectin derivatives
03/10/1999EP0623137B1 Antiparasitic agents
03/04/1999WO1999009976A1 Anti-first-pass effect compounds
03/04/1999WO1999009974A1 4-cyano-4-deformylsordarin derivatives
03/03/1999EP0675893B1 Anticonvulsant sorbopyranose sulfamates
03/03/1999CN1042328C Substituted cyclohexane derivative and medicine containing same
03/02/1999US5877333 1,2-dioxetane derivatives
03/02/1999US5877178 Aids therapy
02/1999
02/25/1999WO1999008676A1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents
02/25/1999DE19833750A1 New thiazolyl-alkadienol and -epoxide derivatives
02/24/1999CN1209132A Macrocyclic compounds made from suboxide units
02/24/1999CN1209131A 1,7-diaroxy-or 1,7-diarylthio-substituted perylene-3,4,9,10-tetracarboxylic acid and their dianhydrides and diimides
02/24/1999CN1042234C Hard coat material comprising high-hard transparent resin
02/23/1999US5874594 Treatment of autoimmune diseases
02/23/1999US5874592 4-(1-oxo,4,6-dimethyldodec-2-en-1-ylamino-),2'-oxo-spiro -(tetrahydrofuran-2,4'-(4,8)dioxatricyclic(5.1.0.0(3,5))octane useful for antiarthritic,-ulcer agents; colitis, nephritis, and hepititus; bactericide; culture product of penicillium
02/23/1999US5874591 Method for the preparation of (±)-calanolide A and intermediates thereof
02/23/1999US5874590 Diaminofluorescein derivative
02/18/1999WO1999007710A1 Macrolides with antitumor activity
02/18/1999WO1999007692A2 New epothilone derivatives, method for producing same and their pharmaceutical use
02/18/1999CA2299608A1 New epothilone derivatives, method for producing same and their pharmaceutical use
02/18/1999CA2299269A1 Macrolides with antitumor activity
02/17/1999CN1208078A Genes encoding branched-chain alpha-ketoacid dehydrogense complex from streptomyces Avermitilis
02/17/1999CN1208038A Chemical matter and its production
02/16/1999US5872264 (+)-calanolide A and analogues thereof
02/16/1999US5871900 Method of inactivating pathogens in biological fluids using photoactivated 5-primaryamino psoralens
02/11/1999WO1998047864A3 N-acetalalkylcarbamates, processes for their preparation and their use as herbicides
02/11/1999WO1998042693A3 NEUTRAL COLOURING PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRANS AND HETEROCYCLIC PYRANS
02/11/1999DE19735578A1 New di:hydroxy-hexanone or -pentene derivatives
02/11/1999DE19735575A1 New di:hydroxy-butanal or -pentene derivatives
02/11/1999DE19735574A1 New 3-hydroxy-5-oxo-hexanoic acid derivatives
02/10/1999EP0895999A1 C-4" substituted macrolide antibiotics
02/10/1999CN1207739A 1,2,3-thiadiazole carboxylic acid (thio) esters and use thereof as pest control agent or as microbicide
02/09/1999US5869702 Polyol ether derivatives and production methods therefor
02/09/1999US5869698 1,2-dioxetane compounds as chemiluminescent labels for organic and biological molecules
02/09/1999US5869662 Photochromic benzopyran compounds
02/09/1999US5869523 Protecting forskolin, deacetylating, treating with beta-halopropionyl halide, treating with alkali, acetylating, reacting with amine, deprotecting
02/09/1999US5869520 Reducing intraocular pressure
02/09/1999US5869514 Terpenoidic derivatives useful as antitumor agents
02/09/1999US5869324 Chiral resolution by contacting mixture with enzyme and acylating agent, separating esterified calanolide a
02/04/1999WO1999005135A1 Polyophenol compounds and drugs containing the same
02/04/1999WO1999004789A1 Substituted aurone derivatives
02/04/1999CA2297753A1 Substituted aurone derivatives
02/03/1999EP0699202B1 Calanolide and related antiviral compounds, compositions, and uses thereof
02/02/1999US5866580 Treating an illness caused by p. carinii and t. gondii
01/1999
01/28/1999WO1999003851A1 Polyglycidyl spirocompounds and their use in epoxy resins
01/28/1999WO1999003848A1 Thiazole derivatives, method for their production and use
01/28/1999WO1999003459A1 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
01/28/1999CA2288828A1 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
01/27/1999EP0892793A1 Substituted tetracyclic tetrahydrofuran derivatives
01/27/1999EP0892780A1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
01/26/1999US5863920 Anticarcinogenic agents and bactericides
01/21/1999WO1999002526A1 Tropane analogs and methods for inhibition of monoamine transport
01/21/1999WO1999002514A2 Epothilone derivatives
01/21/1999WO1998047538A3 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy